Can you prescribe stimulants?

Yes, when clinically appropriate. New York, New Jersey, and Connecticut have specific rules around controlled substances and we follow them carefully.

Do I need a neuropsych eval first?

Not always. Many evaluations happen here directly. If a fuller picture is needed, we refer to a neuropsychologist.

What if I don't tolerate stimulants?

Non-stimulant options like atomoxetine, guanfacine, or bupropion are real alternatives. We will discuss what fits.

Can I be treated for ADHD and another diagnosis at the same time?

Yes. Co-occurring depression, anxiety, or PTSD is common with ADHD. We treat them together rather than asking you to choose.

Treatment areas · 05 of 09

ADHD

Specialized care for Attention Deficit Hyperactivity Disorder for tweens, young adults, and adults. ADHD assessment and treatment with attention to how the diagnosis actually shows up in your life: at school, at work, in relationships, and a plan that accounts for that.

Schedule a consultation ← All treatment areas

Who this is for

Common reasons patients come in.

01
First-time ADHD evaluations, especially in adults who suspect they were missed
02
Adults diagnosed in childhood whose treatment plan stopped working
03
Late-diagnosis adults in their 30s, 40s, and beyond
04
Patients who masked through school and are finding the strategies aren't enough anymore
05
Tweens and young adults navigating school accommodations

In practice

What treatment actually looks like.

No mystery, no choreography. Here’s the structure.

01
Initial evaluation with validated screening (ADHD-RS, sometimes a neuropsych referral if a fuller picture is needed)
02
Discussion of stimulant versus non-stimulant options, including pros and cons of each
03
Stimulant prescribing where appropriate, with regular check-ins on dose and side effects
04
Coordination with school or workplace accommodations when relevant
05
Honest talk about rejection sensitivity, executive function, and how ADHD lives in real adult life

For LGBTQIA+ patients

Specifically, what affirming care looks like for ADHD.

Late ADHD diagnoses are common in queer patients, especially in those who learned to mask through adolescence, and masking is a survival skill many of us already had practice with. Rejection sensitivity dysphoria is a major ADHD feature, and minority stress amplifies it considerably. For trans patients, stimulant medications interact with hormone regimens in subtle ways. Testosterone changes how some stimulants feel, and the cardiovascular shifts during early HRT can intersect with stimulant prescribing. We keep this in view rather than treating ADHD in isolation. Non-binary patients sometimes find that the rigid social structures ADHD struggles with hit harder when those structures are also gendered.

Common questions